摘要
目的探讨人非小细胞肺癌中p16基因表达产物的表达及其临床意义。方法应用免疫组织化学LSAB法检测70例人非小细胞肺癌组织p16基因产物的表达水平,并以20例正常肺组织标本作对照。结果肺癌组织p16基因产物阳性表达率为61.38%,癌旁肺组织为89.14%,正常肺组织为88.24%。肺癌中p16表达水平降低的程度与肺癌细胞分化、原发肿瘤大小和肺癌转移有密切关系(P<0.01或P<0.05),而与肺癌病期、组织学类型、肿瘤部位和患者年龄无明显关系(P>0.05)。结论研究结果表明p16基因可能参与调控肺癌的发生、发展和转移过程。
Objective To explore the expression of p16 gene product and it's clinical significance in human non small cell lung cancer.Methods Expression level of p16 gene product was detected in 70 non small cell lung cancer samples and 20 normal lung tissues as control by immunohistochemistry.Results The expression level in lung cancer (61.38%) was significantly lower than those in adjacent nontumor lung tissue(89.14%) and normal lung tissue (88.24) ( P <0.01). The degree of decreased expression of p16 gene product in lung cancer was closely related to cell differentiation of the tumor, size of the primary tumor, and metastasis of the cancer ( P <0.01 or P <0.05), but not to stages of the tumor, histological classification of the tumor, location of the cancer, and ages of the patients ( P >0.05).Conclusion In this study, the results suggest that p16 gene may be involved in the oncogenesis, development and metastasis of human non small cell lung cancer.
出处
《中国胸心血管外科临床杂志》
CAS
1997年第3期154-156,共3页
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery